Results 1 - 10 of 29
[PROJECT] EUROCANPLATFORM - A European Platform for Translational Cancer Research
ID: 260791
Start date: 2011-01-01, End date: 2016-12-31
Europe has a number of advantages as regards developing translational cancer research, yet there is no clear European strategy to meet the increasing burden posed by cancer. The FP6 Eurocan+Plus project analysed the barriers underlying the increasing fragmentation of cancer r...
Programme: FP7-HEALTH
Record Number: 97701
Last updated on: 2017-05-29
[PROJECT] ANTIFLU - Innovative anti-influenza drugs excluding viral escape
ID: 259842
Start date: 2011-06-01, End date: 2016-11-30
ANTIFLU is to develop innovative drugs against influenza virus infections based on a novel concept that precludes the development of viral resistance and ensures efficacy against upcoming pandemic influenza strains. Viral replication is known to depend on multiple host factor...
Programme: FP7-HEALTH
Record Number: 99759
Last updated on: 2017-05-26
[PROJECT] PANCARESURFUP - PanCare Childhood and Adolescent Cancer Survivor Care and Follow-up Studies
ID: 257505
Start date: 2011-02-01, End date: 2017-01-31
Over the last 40 years, treatment for childhood and adolescent cancer has improved greatly; 5- year survival after childhood cancer is now 80% in developed countries. Approximately 1 individual in 750 of young adults is now a childhood cancer survivor. Epidemiologic data on t...
Programme: FP7-HEALTH
Record Number: 97692
Last updated on: 2017-05-29
[PROJECT] MM4TB - More Medicines for Tuberculosis
ID: 260872
Start date: 2011-02-01, End date: 2016-07-31
The More Medicines for Tuberculosis (MM4TB) consortium evolved from the highly successful FP6 project, New Medicines for TB (NM4TB), that delivered a candidate drug for clinical development two years ahead of schedule. Building on these firm foundations and exploiting its pro...
Programme: FP7-HEALTH
Record Number: 98754
Last updated on: 2017-05-26
[PROJECT] FIT FOR HEALTH - Promoting participation of high-tech research-intensive SMEs in Health
ID: 260748
Start date: 2010-10-01, End date: 2013-09-30
Fit for Health aims to sustainably enhance the participation of European small or medium-sized enterprises (SMEs) in Calls for the FP7 Health Theme. Focusing on research-intensive, high technology SMEs, the project offers targeted support measures, covering the entire innovat...
Programme: FP7-HEALTH
Record Number: 96688
Last updated on: 2017-05-26
The 21st century is full with dangers and challenges. The energy sources are depleted, the climate has changed, the enormously growing human population requires more and safer food and also novel types of antibiotics. Plant growth and agricultural production are seriously...
Programme: FP7-IDEAS-ERC
Record Number: 180321
Last updated on: 2016-04-18
[PROJECT] TINN2 - Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates
ID: 260908
Start date: 2011-01-01, End date: 2015-12-31
The aim of TINN2 is to evaluate azithromycin, included in the EMEA priority list of the therapeutic areas that need specific drug evaluation in preterm and term neonates. Azithromycin is a macrolid antibiotic with anti-inflammatory properties active against Ureaplasma. It mig...
Programme: FP7-HEALTH
Record Number: 96800
Last updated on: 2017-05-29
[PROJECT] EDENEXT - Biology and control of vector-borne infections in Europe
ID: 261504
Start date: 2011-01-01, End date: 2015-06-30
To address the call for proposals 'Biology and control of vector-borne infections in Europe' launched by the European Commission, we want to investigate the biological, ecological and epidemiological components of vector-borne diseases (VBD) introduction, emergence and spread...
Programme: FP7-HEALTH
Record Number: 97622
Last updated on: 2017-05-26
[PROJECT] MEDIA - The MEtabolic Road to DIAstolic Heart Failure
ID: 261409
Start date: 2011-01-01, End date: 2016-06-30
More than 50% of heart failure (HF) patients present without a major deficit of left ventricular (LV) systolic function and are presumed to suffer from diastolic HF (DHF) because diastolic LV distensibility is usually impaired in these patients. The vast majority (~80%) of DH...
Programme: FP7-HEALTH
Record Number: 96870
Last updated on: 2017-05-26
[PROJECT] COPHES - European coordination action on human biomonitoring
ID: 244237
Start date: 2009-12-01, End date: 2012-11-30
This proposal has been elaborated by a consortium of 35 partners coming from 27 European countries and including scientists, government institutions and authorities, NGOs and industry. The main goal is to develop a coherent approach to HBM in Europe as requested by ACTION 3 o...
Programme: FP7-ENVIRONMENT
Record Number: 93956
Last updated on: 2017-05-29
List retrieved on: 2017-08-02
